FDA To Seek Strong Warnings on Epilepsy Drug Labels

FDA will ask pharmaceutical companies to update the labels of 11 epilepsy drugs to include black-box warnings, the most serious warnings FDA issues, about suicidal behavior, according to documents posted on FDA's Web site.

• "FDA Wants Epilepsy-Drug Warnings" (Favole, Wall Street Journal, 7/8).